This article may be too technical for most readers to understand. Please help improve it to make it understandable to non-experts, without removing the technical details. (March 2021) (Learn how and when to remove this template message)

Substituted arylalkylamines are a group of chemical compounds. Two major classes of arylalkylamines include indolylalkylamines (e.g., tryptamines (a.k.a. indolylethylamines)) and phenylalkylamines (e.g., phenethylamines and amphetamines (a.k.a. phenylisopropylamines)), which consist of the monoamine neurotransmitters as well as clinically-used and recreationally-abused monoaminergic drugs, including psychostimulants, anorectics, wakefulness-promoting agents, bronchodilators, decongestants, antidepressants, entactogens, and psychedelics, among others.[1][2][3]

See also

References

  1. ^ Glennon RA (October 1999). "Arylalkylamine drugs of abuse: an overview of drug discrimination studies". Pharmacol. Biochem. Behav. 64 (2): 251–6. doi:10.1016/S0091-3057(99)00045-3. PMID 10515299. S2CID 10221368.
  2. ^ Richard K. Ries; Shannon C. Miller; David A. Fiellin (2009). Principles of Addiction Medicine. Lippincott Williams & Wilkins. pp. 245–. ISBN 978-0-7817-7477-2.
  3. ^ Thomas L. Lemke; David A. Williams (24 January 2012). Foye's Principles of Medicinal Chemistry. Lippincott Williams & Wilkins. pp. 639–. ISBN 978-1-60913-345-0.